A comprehensive exploration of the technological innovations driving drug development in the Indian pharmaceutical industry

Abstract

India is becoming a major participant in the global pharmaceutical scene thanks to technical developments in drug discovery, which have also fuelled advances in safety, personalized medicine, and therapeutic efficacy. Yet issues like infrastructure development of drugs and Ethical and safety and AI and ML Validation and Government and Regularity authority Guidance and regulatory compliance still exist, underscoring the necessity of ongoing funding and cooperation in the pharmaceutical industry. This research work aims to study the AI and ML approaches in clinical trials for a FDA approval. The objectives are studied by conducting a interview with the participants from the industry personnel. Key findings from the research are that training and awareness are required in the industry about the AI involvement in the clinical trials. there should be a regulatory compliance maintained to achieve smooth and diligent protocol for clinical trials with AI for FDA approvals.